Supraventricular tachycardia at 37 weeks with electro cardioversion therapy

Authors

  • Donel S. Department of Obstetrics and Gynecology, Medical Faculty, Riau University, Indonesia
  • Munawar Adhar L. Department of Obstetrics and Gynecology, Medical Faculty, Riau University, Indonesia

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20233652

Keywords:

Supraventricular tachycardia, Pregnancy, Electro-cardioversion

Abstract

The health of both the mother and the fetus is at risk when symptomatic maternal arrhythmias occur during pregnancy. Sustained symptomatic arrhythmias should be managed, much like in the non-pregnant population. The specific arrhythmia that has been identified or is suspected must be treated. Electrical cardioversion (ECV) is used to treat supraventricular arrhythmias when medication therapy and physical therapy, such as sinus carotid massage or Valsalva movements, fail or in life-threatening conditions where the patient is hemodynamically unstable. A 27-year-old primipara came to Bengkalis hospital at 37 weeks of gestation due to complaints of palpitations. palpitations felt since 4 hours before admission to the hospital. The patient had experienced the same complaint and was examined by a cardiologist who said that the patient had a tendency to arrhythmia and was given bisoprolol. An ECG examination was carried out in the emergency room, the impression was supraventricular tachycardia with HR 185 bpm, an abdominal termination of pregnancy was carried out, and the cardiologist performed electro-cardioversion (ECV) in the operating room 3 times, and the mother's HR returned to sinus rhythm. The outcome was a baby girl born with a birth weight of 3200 grams, an Apgar score of 8/9. Mother was treated and went home on the 3rd post-operative day in good condition. Provided that a multidisciplinary approach, continuous fetal heart rate monitoring and the possibility to perform a caesarean section are applied, it can be concluded that cardioversion is a safe and effective treatment for maternal tachycardia in pregnancy.

References

Ibe Ibetoh CN, Stratulat E, Liu F, Wuni GY, Bahuva R, Shafiq MA et al. Supraventricular tachycardia in pregnancy: Gestational and labor differences in treatment. Cureus. 2021;13(10):e18479.

Tromp CHN, Nanne ACM, Pernet PJM, Tukkie R, Bolte AC. Electrical cardioversion during pregnancy: safe or not? Neth Heart J. 2011;19(3):134-6.

Enriquez AD, Economy KE, Tedrow UB. Contemporary management of arrhythmias during pregnancy. Circ Arrhythm Electrophysiol. 2014;7(5):961-7.

Rocher G, Duthoit G, Nizard J, Ladouceur M. Direct-current cardioversion during pregnancy: a series of four procedures in three patients. Eur J Obstet Gynecol Reprod Biol. 2016;206:e178-9.

Ramlakhan KP, Kauling RM, Schenkelaars N, Segers D, Yap S-C, Post MC et al. Supraventricular arrhythmia in pregnancy. Heart. 2022;108(21):1674-81.

Bircher CW, Farrakh S, Gada R. Supraventricular tachycardia presenting in labour: A case report achieving vaginal birth and review of the literature. Obstet Med. 2016;9(2):96-7.

Rijal H, Thapa S, Jha P. Electrical Cardioversion in Pregnancy: A Case Report. Nepal J Obstet Gynaecol. 2022;16(2):85-9.

Ercan S, Davutoglu V, Sari I, Zengin S, Buyukaslan H. Electrical cardioversion in pregnancy: How do we do? J Acad Emerg Med Case Rep. 2014;5(1):10-2.

Tamirisa KP, Elkayam U, Briller JE, Mason PK, Pillarisetti J, Merchant FM et al. Arrhythmias in pregnancy. JACC Clin Electrophysiol. 2022;8(1):120-35.

Georgiopoulos G, Tsiachris D, Kordalis A, Kontogiannis C, Spartalis M, Pietri P et al. Pharmacotherapeutic strategies for atrial fibrillation in pregnancy. Expert Opin Pharmacother. 2019;20(13):1625-36.

Williams DS, Mikhova K, Sodhi S. Arrhythmias and pregnancy: Management of preexisting and new-onset maternal arrhythmias. Cardiol Clin. 2021;39(1):67-75.

Downloads

Published

2023-11-28

Issue

Section

Case Reports